Does contraceptive method change the Pap smear finding?

Contraception

Volumn 66, Issue 4, 2002, Pages 243-246

  Kazerooni, T ^a   Mosalaee, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candidiasis; Dysplasia; Intrauterine device; Oral contraceptive; Tricomonas

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CANDIDIASIS; CELLULAR PARAMETERS; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPITHELIUM; FAMILY PLANNING; FEMALE; FERTILITY; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; IRAN; MAJOR CLINICAL STUDY; METAPLASIA; PAPANICOLAOU TEST; STATISTICAL SIGNIFICANCE; TRICHOMONAS VAGINALIS;

ADULT; AGED; CANDIDIASIS, VULVOVAGINAL; CONTRACEPTION; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRAUTERINE DEVICES; IRAN; MIDDLE AGED; RETROSPECTIVE STUDIES; TRICHOMONAS INFECTIONS; VAGINAL SMEARS;

EID: 0036804538     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(02)00365-7     Document Type: Article

References (17)

1. nd ed. 1993;851-882 McGraw-Hill, Co, New York.
2. Ye Z., Thomas D.B., Ray R.M. The WHO Collaborative Study of Neoplasia, and Steroid Contraceptive. Combined oral contraceptives, and risk of cervical carcinoma in situ. Int J Epidemiol. 24:1995;19-26.
3. Briton L.A. Oral contraceptive and cervical neoplasia. Contraception. 43:1991;581-595.
4. De Vet H.C., Sturmans F. Risk factors for cervical dysplasia implications for prevention . Public Health. 108:1994;241-249.
5. Mclntyre Soltman K. The abnormal Pap smear. Med Clin North Am. 79:1995;1427-1442.
6. Briton L.A., Reeves W.C., Brenes M.M., Herero R., Britto R.C., Gaitan E. Oral Contraceptive use, and risk of invasive cervical cancer. Int J Epidemiol. 19:1990;4-11.
7. Ursin G., Peters R.K., Hendeson B.E., Ablaing G. III, Monroe K.R., Pike M.C. Oral contraceptive use and carcinoma of cervix. Lancet. 344:1994;1390-1394.
8. Shlesselman J.J. Net effect of oral contraceptive use on the risk of cancer in women in the US. Obstet Gynecol. 85:1995;793-801.
9. Eluf Neto J., Booth M., Munoz N., Bosch F.X., Meijer C.J., Walboomers J.M. Human papilloma virus and invasive cervical cancer in Brazil. Br J Cancer. 69:1994;114-119.
10. Brisson J., Morin C., Fortier M., et al. Risk factors for cervical intraepithelial neoplasia, differences between low- and high-grade lesions. Am J Epidemiol. 140:1994;700-710.
11. Bagshaw S. The combined oral contraceptive. Risks and adverse effects in perspective. Drug Safety. 12:1995;91-96.
12. Becker T.M., Wheeler G.M., McGrough N.C., et al. Contraceptive and reproductive risks for cervical dysplasia in south western Hispanic and non-Hispanic white women. Int J Epidemiol. 23:1994;913-922.
13. Lassise D.L., Sartiz D.A., Hamman R.F. Invasive cervical cancer and intrauterine device use. Int J Epidemiol. 20:1991;867-870.
14. Misra Js, Engineer A.D., Das K., et al. Cervical carcinoma and contraception. Diagn Cytopathol. 7:1991;346-352.
15. Ceruti M., Canestrelli M., Condemi V., et al. Methods of contraception and rate of vaginal infections. Clin Exp Obstet Gynecol. 21:1994;119-123.
16. Fiore N. Epidemiology data, cytology, and colposcopy in IUD, OCP, and diaphragm users. Clin Exp Obstet Gynecol. 13:1986;34-42.
17. Barbon F., Austin H., Louv W.C., et al. A follow-up study of methods of contraception, sexual activity, and rate of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol. 163:1990;510-514.